Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

YOU WONT BELIEVE: Haemonetics earnings perspective return on invested capital | Mind Blowing Facts

According to Benzinga Pro, during Q3, Haemonetics (NYSE:HAE) earned $23.23 million, a 56.38% increase from the preceding quarter. Haemonetics also posted a total of $259.77 million in sales, a 8.28% increase since Q2. Haemonetics earned $14.86 million, and sales totaled $239.90 million in Q2.

Why Is ROIC Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.